Literature DB >> 23529646

Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.

Mohammad H El-Dakdouki1, Ellen Puré, Xuefei Huang.   

Abstract

Nanoparticles (NPs) are being extensively studied as carriers for drug delivery, but they often have limited penetration inside tumors. We envision that by targeting an endocytic receptor on the cell surface, the uptake of NPs can be significantly enhanced through receptor mediated endocytosis. In addition, if the receptor is recycled to the cell surface, the NP cargo can be transported out of the cells, which is then taken up by neighboring cells thus enhancing solid tumor penetration. To validate our hypothesis, in the first of two articles, we report the synthesis of doxorubicin (DOX)-loaded, hyaluronan (HA) coated silica nanoparticles (SNPs) containing a highly fluorescent core to target CD44, a receptor expressed on the cancer cell surface. HA was conjugated onto amine-functionalized SNPs prepared through an oil-water microemulsion method. The immobilization of the cytotoxic drug DOX was achieved through an acid sensitive hydrazone linkage. The NPs were fully characterized by transmission electron microscopy (TEM), dynamic light scattering (DLS), zeta potential measurements, thermogravimetric analysis (TGA), UV-vis absorbance, and nuclear magnetic resonance (NMR). Initial biological evaluation experiments demonstrated that compared to ligand-free SNPs, the uptake of HA-SNPs by the CD44-expressing SKOV-3 ovarian cancer cells was significantly enhanced when evaluated in the 2D monolayer cell culture. Mechanistic studies suggested that cellular uptake of HA-SNPs was mainly through CD44 mediated endocytosis. HA-SNPs with immobilized DOX were endocytosed efficiently by the SKOV-3 cells as well. The enhanced tumor penetration and drug delivery properties of HA-SNPs will be evaluated in 3D tumor models in the subsequent paper.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529646      PMCID: PMC3638024          DOI: 10.1039/c3nr33777d

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  73 in total

1.  Hyaluronan: Preparation, Structure, Properties, and Applications.

Authors:  Lubomír Lapcík; Stefaan De Smedt; Joseph Demeester; Peter Chabrecek
Journal:  Chem Rev       Date:  1998-12-17       Impact factor: 60.622

2.  Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells.

Authors:  Mohammad H El-Dakdouki; David C Zhu; Kheireddine El-Boubbou; Medha Kamat; Jianjun Chen; Wei Li; Xuefei Huang
Journal:  Biomacromolecules       Date:  2012-03-13       Impact factor: 6.988

3.  Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.

Authors:  L Y Bourguignon; H Zhu; A Chu; N Iida; L Zhang; M C Hung
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

Review 4.  Nanoparticle delivery of cancer drugs.

Authors:  Andrew Z Wang; Robert Langer; Omid C Farokhzad
Journal:  Annu Rev Med       Date:  2011-09-01       Impact factor: 13.739

Review 5.  Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.

Authors:  R K Jain
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

6.  PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.

Authors:  Ki Young Choi; Kyung Hyun Min; Hong Yeol Yoon; Kwangmeyung Kim; Jae Hyung Park; Ick Chan Kwon; Kuiwon Choi; Seo Young Jeong
Journal:  Biomaterials       Date:  2010-12-14       Impact factor: 12.479

7.  Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging.

Authors:  Yuhan Lee; Haeshin Lee; Young Beom Kim; Jaeyoon Kim; Taeghwan Hyeon; Hyunwook Park; Phillip B Messersmith; Tae Gwan Park
Journal:  Adv Mater       Date:  2008-11-03       Impact factor: 30.849

8.  The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.

Authors:  Kamal K Upadhyay; Anant N Bhatt; Anil K Mishra; Bilikere S Dwarakanath; Sanyog Jain; Christophe Schatz; Jean-François Le Meins; Abdullah Farooque; Godugu Chandraiah; Amit K Jain; Ambikanandan Misra; Sébastien Lecommandoux
Journal:  Biomaterials       Date:  2010-01-06       Impact factor: 12.479

9.  Stem-like ovarian cancer cells can serve as tumor vascular progenitors.

Authors:  Ayesha B Alvero; Han-Hsuan Fu; Jennie Holmberg; Irene Visintin; Liora Mor; Carlos Cano Marquina; Jessica Oidtman; Dan-Arin Silasi; Gil Mor
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

10.  CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts.

Authors:  Jia-Lin Lee; Mei-Jung Wang; Putty-Reddy Sudhir; Jeou-Yuan Chen
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

View more
  9 in total

1.  Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.

Authors:  Dinesh Vyas; Nicolas Lopez-Hisijos; Sulakshana Gandhi; M El-Dakdouki; Marc D Basson; Mary F Walsh; X Huang; Arpita K Vyas; Lakshmi S Chaturvedi
Journal:  J Nanosci Nanotechnol       Date:  2015-09

2.  Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.

Authors:  Seyedmehdi Hossaini Nasr; Zahra Rashidijahanabad; Sherif Ramadan; Nate Kauffman; Narayanan Parameswaran; Kurt R Zinn; Chunqi Qian; Ripla Arora; Dalen Agnew; Xuefei Huang
Journal:  Nanoscale       Date:  2020-05-07       Impact factor: 7.790

3.  Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.

Authors:  Nenad L Ignjatović; Katarina M Penov-Gaši; Victoria M Wu; Jovana J Ajduković; Vesna V Kojić; Dana Vasiljević-Radović; Maja Kuzmanović; Vuk Uskoković; Dragan P Uskoković
Journal:  Colloids Surf B Biointerfaces       Date:  2016-09-28       Impact factor: 5.268

4.  Design of Thiol- and Light-sensitive Degradable Hydrogels using Michael-type Addition Reactions.

Authors:  Prathamesh M Kharkar; Kristi L Kiick; April M Kloxin
Journal:  Polym Chem       Date:  2015-08-21       Impact factor: 5.582

5.  Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.

Authors:  Mohammad H El-Dakdouki; Jingguang Xia; David C Zhu; Herbert Kavunja; Jessica Grieshaber; Sandra O'Reilly; J Justin McCormick; Xuefei Huang
Journal:  ACS Appl Mater Interfaces       Date:  2013-12-12       Impact factor: 9.229

6.  Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia.

Authors:  Timea Simon; Ciprian Tomuleasa; Anca Bojan; Ioana Berindan-Neagoe; Sanda Boca; Simion Astilean
Journal:  Nanoscale Res Lett       Date:  2015-12-01       Impact factor: 4.703

7.  Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems.

Authors:  Beatrice Fortuni; Tomoko Inose; Monica Ricci; Yasuhiko Fujita; Indra Van Zundert; Akito Masuhara; Eduard Fron; Hideaki Mizuno; Loredana Latterini; Susana Rocha; Hiroshi Uji-I
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

8.  Tumor Tropic Delivery of Hyaluronic Acid-Poly (D,L-lactide-co-glycolide) Polymeric Micelles Using Mesenchymal Stem Cells for Glioma Therapy.

Authors:  Xiao-Ling Wang; Wen-Zheng Zhao; Jia-Ze Fan; Le-Chen Jia; Ya-Nan Lu; Ling-Hui Zeng; Yuan-Yuan Lv; Xiao-Yi Sun
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

Review 9.  Targeting hyaluronic acid family for cancer chemoprevention and therapy.

Authors:  Vinata B Lokeshwar; Summan Mirza; Andre Jordan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.